Bare Escentuals Sets Offering Price

April 9, 2007

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

SAN FRANCISCO—About 12 million shares of Bare Escentuals stock (NASDAQ: BARE) were approved for sale March 13 at $34.50 per share. Of these shares, 575,000 shares of common stock are being sold by Bare Escentuals (www.bareescentuals.com) and the remaining shares of common stock are being sold by certain stockholders of the company, including funds affiliated with Berkshire Partners LLC, funds affiliated with JH Partners LLC and certain members of Bare Escentuals’ management. In addition, certain of the selling stockholders have granted the underwriters an option to purchase up to an additional 1.8 million shares at the public offering price.

Goldman, Sachs & Co. is acting as sole book runner for the offering and CIBC World Markets is acting as co-lead manager. Banc of America Securities LLC, Piper Jaffray, Thomas Weisel Partners LLC and SunTrust Robinson Humphrey are acting as co-managers.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like